Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Long-Term European Data Released for SUPERA® Stent from IDEV Technologies

January 26, 2011 By Bio-Medicine.Org

LEIPZIG, Germany, Jan. 26, 2011 /PRNewswire/ — IDEV
Technologies, Incorporated (IDEV), an innovative leader in the
development and commercialization of minimally invasive medical
technologies, today announced the release of two-year European data
from the prominent Leipzig Registry, which tracks patients treated
with the SUPERA wire interwoven nitinol stent.  The SUPERA
stent is CE marked for biliary and peripheral vascular use in
Europe.  In the United States, the SUPERA stent is currently
being studied in an ongoing FDA approved IDE trial for treatment of
peripheral arterial disease of the superficial femoral artery
(SFA).

The single-center registry includes data from 107 patients
treated for peripheral arterial disease of the SFA.  Within
the study population, about a third of the patients had occlusions,
17 percent were categorized as Rutherford 4 or 5, and another 82
percent were Rutherford 3.  Additionally, half the treated
lesions required placement of the SUPERA stent in the distal third
of the SFA.  These highly diseased patients, with severely
calcified lesions, had an average treated lesion length of
approximately 11 centimeters, nearly double that in other stent
trials.  

Results were presented by Sven Braunlich, MD of the Department
of Angiology at Park Hospital and Heart Center, Leipzig, Germany
during the 2011 Leipzig Interventional Course (LINC).  Key
data points include a primary patency rate of 76 percent by duplex
ultrasonography at two years with no stent fractures.  The
12-month patency rate was 85 percent, and the 18-month patency rate
was also 76 percent, showing stable patency from 18 to 24
months.

Dr. Braunlich remarked, “The SUPERA stent has been shown in
independent testing to be extremely crush and fracture resistant
compared to standard nitinol stents.  Combined with the
flexibility of the interwoven design, it is very well suited for
use in the challenging SFA. X-ray

‘/>”/>

SOURCE

Related Articles Read More >

Johnson & Johnson Office of Digital Innovation Leader Peter Schulam
Imagining the future of cloud-connected medical devices with Johnson & Johnson leaders
Withings Body Scan
Withings plans launch for Body Scan smart scale platform
BinaxNow COVID-19 Ag Card
Time recognizes Abbott offerings among this year’s 100 best inventions
Koya Medical’s Dayspring device
Koya Medical reports positive early results in Dayspring lymphedema trial

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech